| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8649448 | Cardiovascular Revascularization Medicine | 2018 | 5 Pages |
Abstract
Lutonix DCB is safe and effective for recurring infrapopliteal disease. It outperforms the OPG for CLI patients with clinical and anatomical high-risk features.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Luis M. Palena, Larry J. Diaz-Sandoval, Efren Gomez-Jaballera, Olga Peypoch-Perez, Enrico Sultato, Cesare Brigato, Enrico Brocco, Marco Manzi,